Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

Journal of Experimental Medicine

Volumn 183, Issue 1, 1996, Pages 195-201

  Foster, Paul S ^a   Hogan, Simon P ^a   Ramsay, Alistair J ^a   Matthaei, Klaus I ^a   Young, Ian G ^a  

^a Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; EOSINOPHILIA; LUNG INJURY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SENSITIZATION;

AEROSOLS; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTOR AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILIA; INTERLEUKIN-5; LUNG; METHACHOLINE CHLORIDE; MICE; MICE, INBRED C57BL; OVALBUMIN; RESPIRATORY SYSTEM;

EID: 0030028768     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.1.195     Document Type: Article

References (33)

1. Bochner, B.S., B.J. Undem, and L.M. Lichtenstein. 1994. Immunological aspects of allergic asthma. Annu. Rev. Immunol. 12:295-335.
2. De Monchy, J.G., H.F. Kauffman, P. Venge, G.H. Koeter, H.M. Jansen, H.J. Sluiter, and K. De Vries. 1985. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131:373-376.
3. Beasley, R., W.R. Roche, J.A. Roberts, and S.T. Holgate. 1989. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139:806-817.
4. Azzawi, M., B. Bradley, P.K. Jeffery, A.J. Frew, A.J. Wardlaw, G. Knowles, B. Assoufi, J.V. Collins, S. Durham, and A.B. Kay. 1990. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Respir. Dis 142:1407-1413.
5. Ohashi, Y., S. Motojima, T. Fukuda, and S. Makino. 1992. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am. Rev. Respir. Dis 145:1469-1476.
6. Walker, C., E. Bode, L. Boer, T.T. Hansel, K. Blaser, and J.C. Virchow, Jr. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109-115.
7. Robinson, D.S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A.M. Bentley, C. Corrigan, S.R. Durham, and A.B. Kay 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326: 298-304.
8. Walker, C., J.C. Virchow, Jr., P.L. Bruijnzeel, and K. Blaser. 1991. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J. Immunol. 146: 1829-1835.
9. Wardlaw, A.J., S. Dunnette, G.J. Gleich, J.V. Collins, and A.B. Kay. 1988. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:62-69.
10. Broide, D.H., G.J. Gleich, A.J. Cuomo, D.A. Coburn, E.C. Federman, L.B. Schwartz, and S.I. Wasserman. 1991. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J. Allergy Clin. Immunol. 88:637-648.
11. Gleich, G.J., N.A. Flavahan, T. Fujisawa, and P.M. Vanhoutte. 1988. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J. Allergy Clin. Immunol. 81:776-881.
12. Sibille, Y., and H.Y. Reynolds. 1990. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141:471-501.
13. Walker, C., M.K. Kaegi, P. Braun, and K. Blaser. 1991. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin. Immunol. 88:935-942.
14. Weller, P.F. 1994. Eosinophils: structure and functions. Curr. Opin. Immunol. 6:85-90.
15. Dahinden, C.A., T. Geiser, T. Brunner, V. von Tscharner, D. Caput, P. Ferrara, A. Minty, and M. Baggiolini. 1994. Monocyte chemotactic protein 3 is a most effective basophil-and eosinophil-activating chemokine. J. Exp. Med. 179:751-756.
16. Rot, A., T. Kneger, T Brunner, S.C Bischoff, T.J. Schall, and C.A. Dahinden. 1992. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176: 1489-1495.
17. Resnick, M.B., and P.F. Weller. 1993. Mechanisms of eosinophil recruitment. Am. J. Respir. Cell Mol. Biol. 8:349-355.
18. Jose, P.J., D.A. Griffiths-Johnson, P.D. Collins, D.T. Walsh, R Moqbel, N.F. Totty, O. Truong, J.J. Hsuan, and T.J. Williams. 1994. Eotaxin: a protein eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179:881-888.
19. Lopez, A.F., C.J. Sanderson, J.R. Gamble, H.D. Campbell, I.G. Young, and M.A. Vadas. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219-224.
20. Yamaguchi, Y., Y. Hayashi, Y. Sugama, Y. Miura, T. Kasahara, S. Kitamura, M. Torisu, S. Mita, A. Tominaga, K. Takatsu, and T. Suda. 1988. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J. Exp. Med. 167:1737-1742.
21. Campbell, H.D., W.Q. Tucker, Y. Hort, M.E. Martinson, G. Mayo, E.J. Clutterbuck, C.J. Sanderson, and I.G. Young. 1987. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). Proc. Natl. Acad. Sci. USA. 84:6629-6633.
22. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A.J. Wardlaw, C.J. Corrigan, B. Bradley, S.R. Durham, J.V. Collins, P.K. Jeffery, et al. 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87: 1541-1546.
23. Mauser, P.S., A. Pitman, A. Witt, X. Fernandez, J. Zurcher, T. Kung, H. Jones, A.S. Watnick, R.W. Gean, W. Kreutner, and G.K. Adams III. 1993. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev. Respir. Dis. 148:1623-1627.
24. Iwama, T., H. Nagai, N. Tsuruoka, and A. Koda. 1993. Effect of murine recombinant interleukin-5 on bronchial reactivity in guinea-pigs. Clin. Exp. Allergy. 23:32-38.
25. Djukanovic, R., J.W. Wilson, K.M. Britten, S.J. Wilson, A.F. Walls, W.R. Roche, P.H. Howarth, and S.T. Holgate. 1990. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am. Rev. Respir. Dis. 142:863-871.
26. Ishida, K., R.J. Thompson, L.L. Seattle, B. Wiggs, and R.R. Schellenberg. 1990. Inhibition of antigen-induced airway hyperresponsiveness, but not acute hyposia nor airway eosinophilia, by an antagonist of platelet-activating factor. J. Immunol. 144:3907-3911.
27. - B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. In press.
28. Ramsay, A.J., and M. Kohonen-Corish. 1993. Interleukin-5 expressed by recombinant virus vector enhances specific mucosal IgA responses in vivo. Eur. J. Immunol. 23:3141-3145.
29. Coffman, R.L., B.W. Seymour, S. Sudak, J. Jackson, and D. Rennick. 1989. Antibody to interleukin-5 inhibits helminth-induced eosoniphilia in mice. Science (Wash. DC). 245:308-310.
30. Kurup, V., H. Choi, S. Murali, and R.L. Coffman. 1994. IgE and eosinophil regulation in a murine model of allergic aspergillosis. J. Leukoc. Biol 56:593-598.
31. Brusselle, G.G., J.C. Kips, J.H. Tavernier, J.G. Van Der Heyden, C.A. Cuvelier, R.A. Pauwels, and H. Bluethmann. 1994. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin. Exp. Allergy. 24:73-80.
32. Ramsay, A.J., A.J. Husband, I.A. Ramshaw, S. Bao, K.I. Matthaei, G. Koehler, and M. Kopf. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science (Wash. DC). 264:561-563.
33. Dubucquoi, S., P. Desreumaux, A. Janin, O. Klein, M. Goldman, J. Tavernier, A. Capron, and M. Capron. 1994. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J. Exp. Med. 179:703-708.